Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox ...(ompanies have committed capital. The fun...),Health
Navigation Links
Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries
Date:2/17/2009
ompanies have committed capital. The fund invests in technologies, products, and services in the U.S. healthcare industry that promote efficiency, lower costs, and improve options for consumers. In a unique partnership, the fund is managed jointly by representatives from the BlueCross BlueShield Association, participating BlueCross BlueShield companies, and Sandbox Industries, a Chicago-based venture capital firm.
Allen & Company LLC served as the exclusive placement agent for the private placement.
About Phreesia
Phreesia is the Patient Check-In Company. Phreesia automates patient check-in and delivers fully interactive content direct-to-patients, designed to interface with physicians' existing and future technology. Replacing the traditional patient clipboard with a free wireless touch screen and swipe-card enabled PhreesiaPad significantly improves the patient check-in experience. Phreesia is backed by premier venture capital firms and draws on the expertise of a leading Medical Advisory Board. www.phreesia.com
About BlueCross BlueShield Venture Fund
BlueCross BlueShield Venture Partners, L.P. is a $116 million corporate venture fund, sponsored by the BlueCross BlueShield Association, a national federation of 39 independent, community-based and locally operated BlueCross BlueShield companies that collectively provide healthcare coverage for more than 102 million individuals -- one in three Americans. The fund's objective is to invest in promising emerging companies of strategic relevance to the 11 BlueCross BlueShield companies that have made voluntary capital commitments.
About Sandbox Industries
Sandbox Industries is an early-stage venture capital firm located in Chicago. Sandbox is the exclusive fund manager of BlueCross BlueShield Venture Partners. Founded in 2003, Sandbox Industr
'/>"/>
| SOURCE Phreesia Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Phreesia Launches at DEMOfall 07
2. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
3. Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
4. Stuart M. Goldstein, Southern New Jersey Patent and Intellectual Property Attorney, secures a New Revolutionary Eco-Friendly Patent
5. Orthomimetics Secures CE Mark Approval for Chondromimetic
6. Precision Therapeutics Secures $43 Million in Venture Capital Funding
7. DFine Secures $30 Million in Series D Funding
8. Ocean Nutrition Canada Limited Secures Their Position as the Largest Omega-3 EPA/DHA Ingredient Supplier in the World
9. Cohera Medical Secures $16.1 Million in Series B Financing
10. Miller, Murtha & Psoras Secures Multimillion-Dollar Settlement for Victim of Industrial Accident at Bethlehem Steel
11. Almost Family Secures $75 Million Revolving Credit Facility
Post Your Comments:
(Date:11/30/2009)... Keynote speaker & Author Dr. Temple Grandi... Corpus Christi, TX (Vocus) November 30, ... is set to be held in Corpus Christi from Thursday... the American Bank Center., , , , ,The conference...e a nearly $300,000 economic impact on the city. T...
(Date:11/30/2009)...YORK, Nov. 30 Reportlinker.com ann...ble in its catalogue: ,, Key Players and Innov...gies in ingredients, pharma, food and drinks ,...s-and-Innovative-Start-Ups-in-Nutraceuticals-Emerg...ks.html ,, Nutraceuticals are bioactive compou...
(Date:11/30/2009)... Nov. 30 - Salon Leau announced tod...December 7(th) to raise funds and create positive ...eases. All proceeds from each haircut and or color...ospital. ,, Salon Leau has been serving the po...ed by LoAnn Lai, widely recognized for her innovat...
(Date:11/30/2009)...VILLE, Tenn., Nov. 30 During this ...r the holidays. For a loved one with Alzheimer,s d...nd friends oftentimes struggle with appropriate gi...the leading providers of senior living residences ... care , offers these suggestions. ,, A listeni...
(Date:11/30/2009)...ov. 30 Physicians at Beth Israel D... results of a study demonstrating the potential fo...CTA) by Rcadia,s COR Analyzer System® to assi...in hospital emergency department (ED ) patients wi... to enhance the use of cCTA has potential to signi...
Breaking Medicine News(10 mins):Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3[0] 18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact[0] Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks[0] Georgetown Hair Salon Helps St. Jude Find A Cure[0] Gift Ideas for Loved Ones with Alzheimer's/Dementia[0] Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease
...PLEASANTON, Calif., FRAMINGHAM, Mass., SYDNEY, Feb...on (Nasdaq: THOR ), a world leader in device-,ba...ve, support and restore,failing hearts, and HeartW...nitive merger agreement under which Thoratec will,...
...ical collaboration and integration of electronic m...out NE Ohio , , CLEVELAND, Feb. 13 Cleveland Cli... MinuteClinic, the pioneer and largest provider of...enient, seven-day-a-week option for those with acu...
... Mr Keith Borowsky, an eminent... Medical School has chosen a Mecmesin MultiTest 10...uct research on a new orthopaedic prosthesis for s...n at the University of Brighton Medical School has...
...laint filed in Superior Court for the Commonwealth...ire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX: Q...al Hospital Corporation, doing business as Massach...Inc. QLT Phototherapeutics (Canada), Inc. was a pr...
...d gender also affect chances of having debilitatin...ay News) -- Being overweight may increase the risk...ults, suggests a U.S. study that included 22,211 p...have migraines than those with smaller waistlines....
... The non-profit Hospice By The...ve care, is offering specialized trainings in end-...sionals in Marin, San Francisco, and Sonoma counti...ngs, which are repeated monthly, contact Hospice,s...
Other Medicine News:Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 2Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 3Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 4Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 5Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 6Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 7Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 2Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 3Health News:Cleveland Clinic Enters into Agreement with MinuteClinic 4Health News:Force Tester Shoulders The Burden 2Health News:QLT announces that it is named as a defendant in an action 2Health News:QLT announces that it is named as a defendant in an action 3Health News:Belly Fat May Make Migraines More Likely 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 3Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;Cleveland Clinic Enters into Agreement with MinuteClinicForce Tester Shoulders The BurdenQLT announces that it is named as a defendant in an actionBelly Fat May Make Migraines More LikelyHospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Infla...nce the Immune Response ,, http://www.reportl...s-That-Suppress-or-Balance-the-Immune-Response.htm...er attacking an individual body or producing an ex...
(Date:11/30/2009)... , WALTHAM, Mass., Nov. 30 /PRNewswire/ -...e global authority on medical technology market in...injectable market declined by almost 5% over 2008 ...a result of the economic crisis. The market will, ... return to the strong pre-recession growth rates o...
(Date:11/30/2009)... , WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewswire...ual Meeting of the Radiological Society of North...Inc. announced the enrollment of the first patient...valuate the efficacy and safety of florbetaben (BA...yloid plaques in the brain, which are a pathologic...
Breaking Medicine Technology:Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3Internet May Be Newest Venue for Teen Tobacco Exposure 52122 1Internet May Be Newest Venue for Teen Tobacco Exposure 52122 2Internet May Be Newest Venue for Teen Tobacco Exposure 52122 3Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 1Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 2Feel Fun Fit 26 Fabulous 21 At the 2009 Womens Health Conference 52117 3Our brain looks at eyes first to identify a face 9280 1Our brain looks at eyes first to identify a face 9280 2Our brain looks at eyes first to identify a face 9280 3[0] Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response[0] Facial Injectables Emerge From the Recession[0] Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
...YVILLE, Calif., Dec. 17 Neurobiological,Technolog...ed that an independent,Data Safety Monitoring Boar...trials of Viprinex(TM) for the treatment of acute ... result, the company has terminated further enroll...e data before evaluating the,potential for any fut...
...YORK, LONDON and HAMILTON, Bermuda, Dec. 16 Celt...announced today that the databases have been locke...uble-blinded studies of XERECEPT (R) (corticoreli...dema, as well as an initial database lock on the o... efficacy. , , The results of these studies a...
Other Medicine Technology:Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |